The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 8-U.S. crude settles lower on worries about Coronavirus vaccine rollout

Fri, 29th Jan 2021 05:59

(New throughout, updates prices, market activity and comments
to settlement)

By Jessica Resnick-Ault

NEW YORK, Jan 29 (Reuters) - U.S. oil prices settled
slightly lower after trading in a tight range on Friday, as
investors worried about the lingering global pandemic and slow
vaccine rollouts.

The most active global Brent crude contract also
ended lower on concerns about vaccine distribution and the
efficacy of one vaccine.

"The vaccine numbers are just not there," said Bob Yawger,
director of energy futures at Mizuho in New York.

Oil markets have rallied about 50% since October on the back
of vaccine rollouts, but the emergence of COVID-19 variants has
fanned worries about economic weakness. Yawger said a U.S.
economic stimulus package may not come quickly enough to support
the market.

U.S. President Joe Biden urged Congress to take swift action
on a $1.9 trillion COVID-19 relief proposal.

"There is no time for any delays," Biden said. "It could
take a year longer to return to full employment if we don't act
and don't act now."

Global benchmark Brent crude futures for March
settled up 36 cents, or 0.6% a barrel, at $55.88. The Brent
March contract expires on Friday. The more active April contract
settled down 6 cents a barrel, at $55.04.

U.S. West Texas Intermediate (WTI) crude futures fell
14 cents, or 0.3%, to $52.20.

Both front-month Brent and WTI were on track to post a
weekly gain of less than 1%.

A Reuters poll showed oil prices are expected to hover
around current levels for much of 2021 before a recovery gains
traction towards year-end.

U.S. crude fell along with stock indexes, as investors
gauged the efficacy data of Johnson & Johnson's COVID-19
vaccine. The drugmaker's shares fell after it said its
single-dose vaccine was 72% effective in preventing COVID-19 in
the United States, with a lower rate of 66% observed globally.

Saudi Arabia is set to cut output by 1 million barrels per
day (bpd) in February and March. Compliance with output curbs by
the Organization of the Petroleum Exporting Countries and
allies, together known as OPEC+, improved in January.

OPEC oil output rose in January, a Reuters survey found,
after OPEC+ agreed to an easing of supply curbs.

However, the rise was less than the agreed amount, with an
involuntary drop in Nigerian exports limiting the increase.
(Reporting by Jessica Resnick-Ault in New York
Additional reporting by Bozorgmehr Sharafedin in London, Roslan
Khasawneh in Singapore and Sonali Paul in Melbourne
Editing by David Goodman, Louise Heavens, David Gregorio and
Richard Chang)

More News
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.